SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure as traders react to the boards investigation into Jensen Huangs admitted affair with a businesswoman reported to have suspected ties to Chinese intelligence, raising concerns about governance, possible information leaks, and Huangs future as CEO. The community is divided between seeing the probe and leadership uncertainty as a serious overhang and treating the controversy as unrelated to Nvidias AI-chip business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is under heavy selling pressure ahead of its Q3 earnings report, with traders speculating about a possible leak while others see the decline as pre-report positioning; a leak is unconfirmed. Bulls point to growth and potential upbeat guidance, while bears worry that the Eli Lilly obesity-drug deal could pressure margins and profitability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy, focused on the amended upper-limb-function evidence from HOPE-3, is driving attention ahead of the Nov. 22 PDUFA date. Bulls cite the trial data and a letter urging approval from 28 investigators, while skeptics point to FDA scrutiny and the earlier negative advisory-panel vote on the cardiac indication; short-squeeze speculation adds to the debate.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing attention after Oppenheimer upgraded the stock, while Google Clouds use of EPYC processors in its AI infrastructure added a company-specific catalyst. Traders also point to money rotating from Nvidia amid a CEO-related investigation, though some see the move as sentiment-driven and question AMDs valuation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are rallying sharply ahead of its Q3 earnings report, with traders speculating about short covering and an earnings leak, though neither explanation is confirmed. The move has fueled hopes for a turnaround, while many investors worry that weak results or guidance could erase the gains.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Post-merger selling in Agility Robotics is drawing attention, with traders pointing to typical de-SPAC volatility and questioning the companys steep losses, limited revenue, and path to commercial scale. Some remain bullish on humanoid robotics and the companys reported orders, but the discussion is dominated by skepticism about valuation and near-term execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet

Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings Gauntlet Weekly Losses Deepen As Small Caps Lag And Yields Edge Higher Into Earnings GauntletPR NewswireNEW YORK, Oct. 1, 2026Stock Preachers News CommentaryNEW YORK, Oct. 1, 2026 /PRNewswire/ --Stocks closed out a choppy...

MKC Q3 Earnings Beat Estimates on Margin Gains and Mexico Growth

McCormick's Q3 earnings beat estimates as Mexico acquisition gains, organic growth and margin expansion lift sales and profitability.


McCormick & Co Q3 2026 Earnings Call Transcript

On Thursday, McCormick & Co (NYSE:MKC) discussed third-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financialread more...

MKC Stock Draws Investor Attention After Volatile Morning Following Upbeat Q3 -- Gross Profit Margin Expands By 190 Basis Points

Equity

McCormick reported Q3 net sales of $2.02 billion and adjusted EPS of $0.86, topping Fiscal AI estimates of $1.98 billion in revenue and $0.76 adjusted EPS.



McCormick (MKC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for McCormick (MKC) give a sense of how the business performed in the quarter ended August 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Earnings Scheduled For October 1, 2026

Companies Reporting Before The Bell
 Accenture (NYSE:ACN) is estimated to report quarterly earnings at $3.18 per share on revenue of $18.03 billion.
 McCormick & Co (NYSE:MKC) is projected to report quarterlyread more...

McCormick (MKC) Surpasses Q3 Earnings and Revenue Estimates

McCormick (MKC) delivered earnings and revenue surprises of +14.67% and +2.34%, respectively, for the quarter ended August 2026. Do the numbers hold clues to what lies ahead for the stock?

McCORMICK REPORTS SOLID THIRD QUARTER PERFORMANCE AND REAFFIRMS 2026 OUTLOOK

McCORMICK REPORTS SOLID THIRD QUARTER PERFORMANCE AND REAFFIRMS 2026 OUTLOOK McCORMICK REPORTS SOLID THIRD QUARTER PERFORMANCE AND REAFFIRMS 2026 OUTLOOKPR NewswireHUNT VALLEY, Md., Oct. 1, 2026HUNT VALLEY, Md., Oct. 1, 2026 /PRNewswire/ -- McCormick& Company, Incorporated (NYSE:MKC), a global...

McCormick Readies for Q3 Earnings: What to Expect From MKC Stock?

McCormick heads into Q3 earnings with expected revenue growth, improving Consumer trends and Flavor Solutions momentum, while cost pressures remain.


Unveiling McCormick (MKC) Q3 Outlook: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for McCormick (MKC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended August 2026.

McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. The firm offers the Aeroplane, Billy Bee, Cattlemen's BBQ Sauce, Cholula, Club House, Club House for Chefs, Drogheria & Alimentari, Ducros, El Guapo, FONA, Frank's RedHot, French's, and other related brands. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.

McCormick & Co., Inc. - Ordinary Shares (Non Voting)

Bearish Sentiment

<ul class="summary-bullets"><li>McCormick reaffirmed 2026 guidance, including 13% to 17% sales growth and $3.05 to $3.13 adjusted EPS.</li><li>Organic sales increased 1.9% during the quarter, driven by a 2.2% increase from pricing, partially offset by a 0.3% decline in volume and product mix.</li><li>Unilever Foods integration remains on track, with $600M in expected annual run-rate cost synergies.</li></ul>McCormick &amp; Company Inc. (<a href="https://stocktwits.com/symbol/MKC">MKC</a>) shares dropped on Thursday morning&nbsp;as the flavor and seasoning company reported fiscal third-quarter results that topped estimates and reaffirmed its fiscal 2026 outlook. The stock surged as much as 6% in premarket trading before paring most of its gains, as of this writing.McCormick reported third-quarter net sales of $2.02 billion, up 17.4% year-over-year, while adjusted earnings came in at $0.86 per share. According to estimates from Fiscal AI, analysts were expecting revenue of about $1.98 billion and adjusted earnings per share (EPS) of $0.76.Organic sales increased 1.9% during the quarter, driven by a 2.2% increase from pricing, partially offset by a 0.3% decline in volume and product mix. Sales also benefited from the McCormick de Mexico acquisition, which accounted for 14% of the overall sales increase.<h2 class="st-heading-2">McCormick Highlights Margin Expansion, Productivity Gains</h2>Gross profit increased by $150 million from the year-ago period, while gross profit margin expanded by 190 basis points to 39.3%. Adjusted operating income increased 22.1% to $358.5 million, with adjusted operating margin expanding 70 basis points to 17.7%.McCormick said the improvement in gross profit margin was driven by the McCormick de Mexico acquisition, higher sales and cost savings from its Comprehensive Continuous Improvement (CCI) program, partially offset by higher commodity and freight costs.“Disciplined productivity initiatives helped offset rising input and freight costs, supporting margin expansion and enabling continued investment in our brands to drive long-term profitable growth,” said Brendan M. Foley, Chairman, President and Chief Executive Officer of McCormick &amp; Company.Foley said the quarter reflected a solid base-business contribution and accretion from McCormick de México, where the company has substantially completed its integration. He added that McCormick’s enhanced margin profile and operational discipline position the company to continue investing in its brands, capabilities and innovation.<h2 class="st-heading-2"><a class="mention" data-mention="$MKC" data-symbol-id="MKC" href="https://stocktwits.com/symbol/MKC" target="_blank">MKC</a> Reaffirms Fiscal 2026 Outlook</h2>McCormick reaffirmed its fiscal 2026 outlook, including net sales growth of 13% to 17%, adjusted operating income growth of 16% to 20% and adjusted EPS of $3.05 to $3.13.The company continues to expect organic sales growth of 1% to 3% for the year. McCormick said its outlook reflects continued investments in key categories, productivity initiatives through its CCI program and the contribution from McCormick de Mexico.“Overall, performance reflected solid base business contribution and accretion from the McCormick de Mexico acquisition,” Foley said, adding that strong year-to-date performance, including organic growth, margin expansion and robust cash flow, gives the company confidence in delivering its 2026 outlook.<h2 class="st-heading-2">Unilever Foods Deal Integration Remains On Track</h2>McCormick said integration planning for its proposed combination with Unilever’s Foods business remains on track. The company has established the future operating model and leadership team, set up a dedicated Integration Management Office and mobilized 20 cross-functional teams comprising more than 200 employees from McCormick and Unilever Foods.The company said its Day 1 planning has identified specific integration initiatives, while transition service agreements are in place to support business continuity after the deal closes.McCormick expects the combined company to realize approximately $600 million in annual run-rate cost synergies, net of growth reinvestments and potential dis-synergies, with approximately two-thirds expected to be achieved by Year 2 following the close.The company also expects to identify approximately $100 million in additional cost and revenue synergies that would be reinvested to support growth. McCormick expects the transaction to deliver mid- to high-single-digit adjusted EPS accretion within the first 12 months after closing and mid- to high-teens accretion in Year 3.The transaction is expected to close by mid-2027, subject to customary closing conditions and regulatory approvals.<h2 class="st-heading-2">Retail View On <a class="mention" data-mention="$MKC" data-symbol-id="MKC" href="https://stocktwits.com/symbol/MKC" target="_blank">MKC</a></h2>On Stocktwits, retail sentiment surrounding the stock has improved to ‘extremely bullish’&nbsp; amid ‘high’ message volumes in the past 24 hours.<a class="mention" data-mention="$MKC" data-symbol-id="MKC" href="https://stocktwits.com/symbol/MKC" target="_blank">MKC</a> stock has declined by more than 35% so far this year.Also read: &nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rklb-stock-a-core-holding-for-space-bulls-analyst-says-sees-43-upside-as-synspective-deal-boosts-backlog/cZD02dmRBin">RKLB Stock A ‘Core Holding For Space Bulls,’ Analyst Says – Sees 43% Upside As Synspective Deal Boosts Backlog</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

McCormick spices displayed at a San Anselmo, California store on June 26, 2025. (Photo Illustration by Justin Sullivan/Getty Images)

McCormick & Company Inc. (MKC) shares rose about 6% in premarket trading on Thursday after the flavor and seasoning company reported fiscal third-quarter results that topped estimates and reaffirmed its fiscal 2026 outlook.

Track MKC stock price, charts, news and real-time market activity on Stocktwits. Join the MKC message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around McCormick & Company stock.

MKC Stock Price Today - McCormick & Co News, Charts, Retail Sentiment

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$0.78	--	--	N/A
Q3 '26	$0.76	$0.86	13.88%	BEAT
Q2 '26	$0.69	$0.80	15.57%	BEAT
Q1 '26	$0.59	$0.66	11.19%	BEAT
Q4 '25	$0.88	$0.86	-1.85%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

MKC Earnings

Upcoming Earnings: Q4 '26

Historical Earnings